NCT06076733

Brief Summary

To investigate the effect of high definition-transcranial alternating current stimulation(HD-tACS) on consciousness promotion in patients with chronic consciousness disorders and the underlying neural mechanism by EEG.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 21, 2023

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

October 2, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 11, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2025

Completed
Last Updated

October 12, 2023

Status Verified

October 1, 2023

Enrollment Period

2 years

First QC Date

October 2, 2023

Last Update Submit

October 11, 2023

Conditions

Keywords

DOC tACS

Outcome Measures

Primary Outcomes (1)

  • Assessment of Coma Recovery Scale

    State of consciousness was assessed by two trained physicians in three different time periods using the Coma Recovery Scale-Revised (CRS-R), which has demonstrated good reliability and validity for the behavioral evaluation of disorder of consciousness (DOC) patients. Total score ranges from zero to twenty-three, with higher scores indicating better neurological function and prognosis.

    Before intervention and one day after all intervention

Study Arms (2)

active group

EXPERIMENTAL

Twenty 2-mA sessions (ramp-up and ramp-down periods of 30 and 30 seconds, respectively) were applied for 20 minutes per session, twice daily over 10 consecutive days, and the stimulus frequency was set as 6Hz.

Device: high definition-transcranial alternating current stimulation

sham group

SHAM COMPARATOR

Sham tACS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.

Device: sham transcranial alternating current stimulation

Interventions

tACS is described as a non-invasive form of brain stimulation that uses a low-intensity, alternating current applied directly to the head through scalp electrodes.

active group

Sham tACS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.

sham group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients diagnosed as chronic disorders of consciousness based on CRS-R assessment by at least two professional neurologists;
  • the age requirement is between 18 and 75;
  • vital signs need to be stable;
  • no neuromuscular blockers and sedatives have been used within 24 hours before the study and the entire protocol;
  • no improvement in the state of consciousness was observed within one week before the start of the study.

You may not qualify if:

  • previous or current diagnosis of severe neurocognitive degenerative diseases;
  • metal implantation in the head;
  • previous surgical procedures resulted in skull defect;
  • previous history of epilepsy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Anhui Medical University

Hefei, Anhui, China

RECRUITING

MeSH Terms

Conditions

Consciousness Disorders

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Kai Wang, PhD

    Director of medical psychological department, Anhui Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of medical psychological department, Anhui Medical University

Study Record Dates

First Submitted

October 2, 2023

First Posted

October 11, 2023

Study Start

September 21, 2023

Primary Completion

September 20, 2025

Study Completion

September 20, 2025

Last Updated

October 12, 2023

Record last verified: 2023-10

Locations